ABOUT PROLEVIATE CONOLIDINE BENEFITS PATIENTS

This is often an open-obtain short article distributed beneath the conditions from the Innovative Commons Attribution-NonCommercial 4.0 Worldwide License () which permits duplicate and redistribute the material just in noncommercial usages, furnished the original operate is thoroughly cited.Ongoing exploration is focused on synthesizing derivatives